Rectify Pharmaceuticals
About:
Rectify Pharmaceuticals is a biotechnology company developing Positive Functional Modulators (PFMs), disease-modifying therapeutics.
Website: https://rectifypharma.com/
Twitter/X: RectifyPharma
Top Investors: Atlas Venture, Longwood Fund, Omega Funds, Forbion Capital Partners
Description:
Rectify is developing disease-modifying precision therapies that restore ABC transporter function to address the underlying cause of serious genetic diseases. The company’s pipeline spans multiple therapeutic areas.
Total Funding Amount:
$100M
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
Cambridge, Massachusetts, United States
Founded Date:
2020-01-01
Contact Email:
info(AT)rectifypharma.com
Founders:
Jonathan Moore
Number of Employees:
11-50
Last Funding Date:
2021-10-14
IPO Status:
Private
Industries:
© 2025 bioDAO.ai